FABP1 and steatosis: The treatment with curcumin-andrographolide in association maintained the ability to regulate in a negative manner FABP1 (15.96 times), PPARGC1A (7.85 times), GK and ABCA1 (4 times), and APOC3 (2.04 times) in respect to the steatosis control.